Last reviewed · How we verify
NCT03723577
An Evaluation of a Fibrillar Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
NA trial testing Fibrillar collagen powder dressing in Wound. Withdrawn.
14 May 2019
Quick facts
| Lead sponsor | Medline Industries |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 15 November 2018 |
| Primary completion | 14 May 2019 |
| Estimated completion | 14 May 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Fibrillar collagen powder dressing
Conditions studied
- Wound — all drugs for Wound →
Sponsor
Medline Industries — full company profile →
Who can join
18 and older, any sex, with Wound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with an appropriate moisture retentive secondary dressing. Patients will visit the clinic twice a week to have the powder re-applied. Wound evaluations will take place once a week at the outpatient clinic, with the intervention lasting up to twelve weeks. Concurrent standard of care, such as compression for venous ulcers, will be provided.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical research nurse predictions of trial failure, recruitment and retention: a case for their early inclusion in trial design.
Shiely F, Murphy D, Millar SR. · · 2023 · cited 5× · PMID 37464255 · DOI 10.1186/s13063-023-07504-9
Verify or expand the search:
- PubMed search for NCT03723577
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fibrillar collagen powder dressing
Trials testing the same drug.
- NCT03723603 — An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds · NA · terminated
Other recruiting trials for Wound
Currently open trials in the same condition.
- NCT07398534 — PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC) · NA · active not recruiting
- NCT06957964 — Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial · NA · recruiting
- NCT06801626 — Novel Strategies for Reducing Burn Scar Itch · Phase 3 · recruiting
- NCT06321978 — Mepilex Border Flex Utilization Pilot Spain · recruiting
- NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting
Other Medline Industries trials
Trials by the same sponsor.
- NCT05755282 — Touch and Feel Evaluation of Two Foam Hand Sanitizers · Phase 4 · completed
- NCT05740332 — Wet Time for a Foam Hand Sanitizer · Phase 4 · completed
- NCT05756348 — Durability of Two Skin Barrier Protectants (SBP) · NA · completed
- NCT05742347 — Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions · NA · terminated
- NCT05250102 — Neonatal Pulse Oximetry Sensor Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03723577 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medline Industries
- Last refreshed: 21 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03723577.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing